{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:49:08Z","timestamp":1793774948003,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neo.2022.100785","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T13:17:15Z","timestamp":1649078235000},"page":"100785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction"],"prefix":"10.1016","volume":"28","author":[{"given":"Hayley M.","family":"Sabol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-0283","authenticated-orcid":false,"given":"Cody","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Halladay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meloney","family":"Cregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intawat","family":"Nookaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. David","family":"Roodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita","family":"Bellido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-2774","authenticated-orcid":false,"given":"Jesus","family":"Delgado-Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2022.100785_bib0001","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.24236","article-title":"Myeloma today: Disease definitions and treatment advances","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Am. J. Hematol"},{"key":"10.1016\/j.neo.2022.100785_bib0002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17474086.2013.874943","article-title":"Management of bone disease in multiple myeloma","volume":"7","author":"Terpos","year":"2014","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.neo.2022.100785_bib0003","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/CCO.0000000000000615","article-title":"The microenvironment in myeloma","volume":"32","author":"Lomas","year":"2020","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.neo.2022.100785_bib0004","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","article-title":"Notch signaling in the tumor microenvironment","volume":"34","author":"Meurette","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2022.100785_bib0005","first-page":"20","article-title":"The multifunctional role of Notch signaling in multiple myeloma","volume":"7","author":"Sabol","year":"2021","journal-title":"J. Cancer Metast. Treat."},{"key":"10.1016\/j.neo.2022.100785_bib0006","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-15-1703","article-title":"Bidirectional notch signaling and osteocyte-derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma","volume":"76","author":"Delgado-Calle","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2022.100785_bib0007","doi-asserted-by":"crossref","first-page":"56013","DOI":"10.18632\/oncotarget.10820","article-title":"Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche","volume":"7","author":"Colombo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100785_bib0008","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4149\/neo_2013_005","article-title":"Notch1 overexpression promotes cell growth and tumor angiogenesis in myeloma","volume":"60","author":"Guo","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.neo.2022.100785_bib0009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bcmd.2012.01.006","article-title":"Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells","volume":"48","author":"Chiron","year":"2012","journal-title":"Blood Cells Mol. Dis"},{"key":"10.1016\/j.neo.2022.100785_bib0010","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/leu.2011.332","article-title":"Dll1\/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation","volume":"26","author":"Xu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2022.100785_bib0011","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1158\/0008-5472.CAN-21-0524","article-title":"Targeting notch inhibitors to the myeloma bone marrow niche decreases tumor growth and bone destruction without gut toxicity","volume":"81","author":"Sabol","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2022.100785_bib0012","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1038\/bcj.2014.37","article-title":"Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model","volume":"4","author":"Schwarzer","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.neo.2022.100785_bib0013","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/1535-7163.MCT-10-0372","article-title":"Combined inhibition of Notch signaling and Bcl-2\/Bcl-xL results in synergistic antimyeloma effect","volume":"9","author":"Li","year":"2010","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.neo.2022.100785_bib0014","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/leu.2011.192","article-title":"MRK003, a gamma-secretase inhibitor exhibits promising in vitro preclinical activity in multiple myeloma and non-Hodgkin\u2019s lymphoma","volume":"26","author":"Ramakrishnan","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2022.100785_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/156802608783334015","article-title":"Therapeutic potential of gamma-secretase inhibitors and modulators","volume":"8","author":"Imbimbo","year":"2008","journal-title":"Curr. Top. Med. Chem"},{"key":"10.1016\/j.neo.2022.100785_bib0016","doi-asserted-by":"crossref","first-page":"46107","DOI":"10.1074\/jbc.M307757200","article-title":"Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor","volume":"278","author":"Searfoss","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neo.2022.100785_bib0017","doi-asserted-by":"crossref","first-page":"26826","DOI":"10.18632\/oncotarget.5025","article-title":"Notch signaling deregulation in multiple myeloma: A rational molecular target","volume":"6","author":"Colombo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100785_bib0018","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1152\/physrev.00043.2020","article-title":"The osteocyte as a signaling cell","volume":"102","author":"Delgado-Calle","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neo.2022.100785_bib0019","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2003-07-2340","article-title":"Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines","volume":"103","author":"Nefedova","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.neo.2022.100785_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neo.2022.100785_bib0021","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.neo.2022.100785_bib0022","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/hmg\/ddh260","article-title":"BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer","volume":"13","author":"Taron","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neo.2022.100785_bib0023","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3324\/haematol.2011.047993","article-title":"High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse","volume":"96","author":"Shalapour","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.neo.2022.100785_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.leukres.2013.08.015","article-title":"The clinical significance of cereblon expression in multiple myeloma","volume":"38","author":"Schuster","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.neo.2022.100785_bib0025","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.ajpath.2012.01.040","article-title":"The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma","volume":"180","author":"Cooper","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neo.2022.100785_bib0026","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/nar\/gkt111","article-title":"Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods","volume":"41","author":"Varemo","year":"2013","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.neo.2022.100785_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10345","article-title":"Ex vivo organ cultures as models to study bone biology","volume":"4","author":"Bellido","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/j.neo.2022.100785_bib0028","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.18632\/oncotarget.26831","article-title":"Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts","volume":"10","author":"Delgado-Calle","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100785_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"Kyle","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2022.100785_bib0030","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V93.5.1697","article-title":"Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease","volume":"93","author":"Dallas","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.neo.2022.100785_bib0031","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S8756-3282(97)00056-2","article-title":"A murine model of human myeloma bone disease","volume":"20","author":"Garrett","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.neo.2022.100785_bib0032","first-page":"593","article-title":"Animal model of human disease. Multiple myeloma","volume":"132","author":"Radl","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neo.2022.100785_bib0033","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.V90.6.2437","article-title":"New xenograft model of multiple myeloma and efficacy of a humanized antibody against human interleukin-6 receptor","volume":"90","author":"Tsunenari","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.neo.2022.100785_bib0034","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/leu.2017.152","article-title":"Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth","volume":"31","author":"Delgado-Calle","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2022.100785_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13045-018-0666-5","article-title":"Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis","volume":"11","author":"Petrusca","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.neo.2022.100785_bib0036","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.thj.6200052","article-title":"The 5TMM series: a useful in vivo mouse model of human multiple myeloma","volume":"1","author":"Asosingh","year":"2000","journal-title":"Hematol. J."},{"key":"10.1016\/j.neo.2022.100785_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030485","article-title":"Notch3 in development, health and disease","volume":"10","author":"Hosseini-Alghaderi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neo.2022.100785_bib0038","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of notch in cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neo.2022.100785_bib0039","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.2084","article-title":"Notch signaling drives multiple myeloma induced osteoclastogenesis","author":"Colombo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100785_bib0040","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell ... and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.neo.2022.100785_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116074","article-title":"Reorganization of the osteocyte lacuno-canalicular network characteristics in tumor sites of an immunocompetent murine model of osteotropic cancers","volume":"152","author":"Hemmatian","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.neo.2022.100785_bib0042","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10637-019-00754-y","article-title":"A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumors","volume":"38","author":"Rosen","year":"2020","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.neo.2022.100785_bib0043","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jcp.28960","article-title":"An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice","volume":"235","author":"Yu","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neo.2022.100785_bib0044","doi-asserted-by":"crossref","first-page":"14165","DOI":"10.1074\/jbc.RA118.004242","article-title":"The lateral meningocele syndrome mutation causes marked osteopenia in mice","volume":"293","author":"Canalis","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2022.100785_bib0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11914-020-00613-3","article-title":"New and old osteocytic cell lines and 3D models","volume":"18","author":"Pajevic","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.neo.2022.100785_bib0046","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-15-1703","article-title":"Bidirectional notch signaling and osteocyte-derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma","volume":"76","author":"Delgado-Calle","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2022.100785_bib0047","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/leu.2011.381","article-title":"Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation","volume":"26","author":"Giuliani","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2022.100785_bib0048","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2017-03-773341","article-title":"Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.neo.2022.100785_bib0049","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jbmr.2741","article-title":"The proteasome inhibitor bortezomib maintains osteocyte viability in multiple myeloma patients by reducing both apoptosis and autophagy: a new function for proteasome inhibitors","volume":"31","author":"Toscani","year":"2016","journal-title":"J. Bone Miner. Res"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:09:55Z","timestamp":1761484195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558622000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"alternative-id":["S1476558622000148"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2022.100785","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2022.100785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100785"}}